Clinical Trials Logo

Clinical Trial Summary

The purpose of the Kaligia Biosciences KBS Systems 1.0(b) analyte monitoring device is to measure the blood analyte levels in patients. The KBS Systems 1.0(b) device avoids the common practice of accessing the vein to draw blood for conventional laboratory analysis. Instead, the KBS Systems 1.0(b) device uses Raman Spectroscopy to acheive the measurement of various blood analytes through the use of only approximately 40µl of blood. Such a small volume of blood can be sampled via a finger prick procedure rather than needing a larger volume of blood sampled via a venipuncture. The spectra contain information of all the molecules present in the blood (RBCs, hemoglobin, glucose, sodium, potassium, etc.). From these spectra, the system is able to analyze the blood and provide results in a matter of minutes, rather than hours or even, in some cases, days.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Calibration and Validation of Analyte Testing System

NCT number NCT04305938
Study type Observational
Source Kaligia Biosciences, LLC
Contact Janice Shirley, MPH
Phone 813-919-8857
Email advancedclinicalresearch@yahoo.com
Status Not yet recruiting
Phase
Start date April 1, 2020
Completion date December 31, 2020